ATE340571T1 - Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen - Google Patents

Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen

Info

Publication number
ATE340571T1
ATE340571T1 AT01942551T AT01942551T ATE340571T1 AT E340571 T1 ATE340571 T1 AT E340571T1 AT 01942551 T AT01942551 T AT 01942551T AT 01942551 T AT01942551 T AT 01942551T AT E340571 T1 ATE340571 T1 AT E340571T1
Authority
AT
Austria
Prior art keywords
trka
turn
beta
extracellular domain
peptidomimmetic
Prior art date
Application number
AT01942551T
Other languages
English (en)
Inventor
Horacio Uri Saragovi
Kevin Burgess
Original Assignee
Univ Mcgill
Texas A & M Univ Sys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill, Texas A & M Univ Sys filed Critical Univ Mcgill
Application granted granted Critical
Publication of ATE340571T1 publication Critical patent/ATE340571T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01942551T 2000-01-18 2001-01-18 Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen ATE340571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17648200P 2000-01-18 2000-01-18

Publications (1)

Publication Number Publication Date
ATE340571T1 true ATE340571T1 (de) 2006-10-15

Family

ID=22644525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942551T ATE340571T1 (de) 2000-01-18 2001-01-18 Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen

Country Status (9)

Country Link
US (1) US6881719B2 (de)
EP (1) EP1265605B1 (de)
AT (1) ATE340571T1 (de)
AU (1) AU2001228212A1 (de)
CA (1) CA2397670C (de)
DE (1) DE60123399T2 (de)
DK (1) DK1265605T3 (de)
ES (1) ES2273849T3 (de)
WO (1) WO2001052843A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923216B2 (en) * 1997-08-14 2011-04-12 Institut Pasteur In vivo modulation of neuronal transport
US7923015B2 (en) 1997-08-14 2011-04-12 Institut Pasteur Methods for direct visualization of active synapses
US7566765B2 (en) * 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
AU2002259305A1 (en) 2001-05-25 2002-12-09 Cornell Research Foundation, Inc. High affinity ligand for p75 neurotrophin receptor
AUPR604401A0 (en) * 2001-06-29 2001-07-26 University Of Wollongong, The Peptoid compounds
ES2357948T3 (es) 2002-10-08 2011-05-04 Rinat Neuroscience Corp. Procedimientos para tratar dolor postquirúrgico mediante la administración de un anticuerpo frente al factor de crecimiento nervioso y composiciones que contienen el mismo.
WO2005000194A2 (en) 2002-10-08 2005-01-06 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
CA2511598C (en) 2002-12-24 2016-09-13 Rinat Neuroscience Corp. Anti-ngf antibodies and methods using same
PL378582A1 (pl) 2003-03-19 2006-05-02 Biogen Idec Ma Inc. Białko wiążące receptor Nogo
EP2210612B1 (de) 2003-06-18 2016-10-05 Ocera Therapeutics, Inc. Makrozyklische Motilin Rezeptorantagonisten
ITRM20030601A1 (it) * 2003-12-24 2005-06-25 Lay Line Genomics Spa Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
DK2206728T3 (en) 2004-04-07 2018-04-23 Rinat Neuroscience Corp METHODS OF TREATING BONE CANCER PAIN BY SUBMITTING A NERVOUS FACTOR-ANTAGONISTIC ANTIBODY
EP2474317A1 (de) 2004-06-24 2012-07-11 Biogen Idec MA Inc. Behandlung von Zuständen einhergehend mit Demyelisation
US8637464B2 (en) 2004-07-14 2014-01-28 Janssen Pharmaceutica N.V. P75NTR screening assay
EP1810028A2 (de) * 2004-10-14 2007-07-25 Rigel Pharmaceuticals, Inc. Heterocyklische inhibitoren von ires-vermittelter translation und verwendungverfahren damit
US20110230479A1 (en) * 2005-04-15 2011-09-22 Longo Frank M Neurotrophin mimetics and uses thereof
US7723328B2 (en) * 2005-04-15 2010-05-25 The University Of North Carolina At Chapel Hill Methods of facilitating cell survival using neurotrophin mimetics
ITRM20050290A1 (it) * 2005-06-07 2006-12-08 Lay Line Genomics Spa Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
US8686045B2 (en) 2005-06-08 2014-04-01 The University Of North Carolina At Chapel Hill Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
ES2434470T3 (es) 2005-07-08 2013-12-16 Biogen Idec Ma Inc. Anticuerpos SP35 y usos de éstos
EP2068866A4 (de) 2006-07-24 2010-04-07 Biogen Idec Inc Verfahren zur förderung von myelinisierung, neuronalem überleben und oligodendrozytendifferenzierung mittels verabreichung von sp35- bzw. trka-antagonisten
AU2011253937B2 (en) * 2006-12-05 2012-09-27 The Royal Institution For The Advancement Of Learning/ Mcgill University Methods of use of TRK receptor modulators
CN101657212B (zh) * 2006-12-05 2014-03-19 皇家学习促进会/麦吉尔大学 Trk受体调节剂的使用方法
EP2205071B1 (de) * 2007-10-11 2015-07-22 Biogen MA Inc. Lingo-1-antagonisten und trkb-agonisten zur verwendung zur behandlung von glaukom
US20110123553A1 (en) * 2007-11-08 2011-05-26 Biogen Idec Ma Inc. Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination
EP2271337B1 (de) 2008-04-04 2014-09-03 Mimetogen Pharmaceuticals Inc. Beta-turn-peptidomimetische zyklische verbindungen zur behandlung von trockenen augen
NZ590605A (en) 2008-07-09 2012-11-30 Biogen Idec Inc Compositions comprising antibodies to lingo or fragments thereof
CN102333537B (zh) * 2009-02-27 2014-08-13 米梅托根药物公司 用于治疗色素性视网膜炎的模拟肽环状化合物
US10273219B2 (en) 2009-11-12 2019-04-30 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
CN102740856B (zh) 2009-11-12 2015-02-18 特罗菲克斯制药股份有限公司 神经营养蛋白模拟化合物及其盐的晶型
KR102142161B1 (ko) 2012-05-14 2020-08-06 바이오젠 엠에이 인코포레이티드 운동 뉴런 관련 병태 치료용 lingo-2 길항제
US9115179B2 (en) 2012-06-22 2015-08-25 Mimetogen Pharmaceuticals Inc. Synthesis of beta-turn peptidomimetic cyclic compounds
EP2970098B1 (de) 2013-03-15 2020-01-08 Pharmatrophix Inc. Nichtpeptidische bdnf-neurotrophin-mimetika
AU2014228017B2 (en) 2013-03-15 2018-08-30 Pharmatrophix, Inc. Non-peptide BDNF Neurotrophin mimetics
US9657059B2 (en) 2013-09-09 2017-05-23 Canimguide Therapeutics Ab Immune system modulators
US10435467B2 (en) 2015-01-08 2019-10-08 Biogen Ma Inc. LINGO-1 antagonists and uses for treatment of demyelinating disorders
ES2853582T3 (es) 2015-03-06 2021-09-16 Canimguide Therapeutics Ab Moduladores del sistema inmune y composiciones
KR102056257B1 (ko) 2015-07-09 2019-12-16 미메토젠 파르마슈티칼스 인크. 베타-턴 펩티도미메틱 사이클릭 염의 용액상 합성 및 결정화
US20230312651A1 (en) * 2020-07-10 2023-10-05 The University Of Tokyo Cyclic Peptide, Peptide Complex, and Drug Composition Containing Said Cyclic Peptide and/or Said Peptide Complex
AU2022283808A1 (en) * 2021-06-02 2023-12-07 The Texas A&M University System Selective small molecule agonists and partial agonists of trk receptors
JP2025527299A (ja) * 2022-08-05 2025-08-20 ザ テキサス エーアンドエム ユニバーシティ システム 医療用途のための色素結合環化ペプチドのための組成物および方法
FR3148027A1 (fr) * 2023-04-24 2024-10-25 Peptinov Composition vaccinale anti-ngf

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034224A (en) * 1989-05-30 1991-07-23 American Cyanamid Company Method and composition for treating protozoal infections
DE69110906T2 (de) * 1990-12-21 1995-11-16 Hsc Research Dev Ltd Partnersh Verwendung von Wirtszellphospholipiden zur Hemmung bakterieller Besiedlung.
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses

Also Published As

Publication number Publication date
US20030211982A1 (en) 2003-11-13
CA2397670C (en) 2010-06-08
WO2001052843A1 (en) 2001-07-26
EP1265605B1 (de) 2006-09-27
CA2397670A1 (en) 2001-07-26
DK1265605T3 (da) 2007-02-12
DE60123399T2 (de) 2007-08-23
ES2273849T3 (es) 2007-05-16
DE60123399D1 (de) 2006-11-09
EP1265605A1 (de) 2002-12-18
AU2001228212A1 (en) 2001-07-31
US6881719B2 (en) 2005-04-19

Similar Documents

Publication Publication Date Title
ATE340571T1 (de) Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen
Contreras et al. Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone.
Hopf et al. Dimerization of the muscle-specific kinase induces tyrosine phosphorylation of acetylcholine receptors and their aggregation on the surface of myotubes
DE60132017D1 (de) Neue benzazepine und ähnliche heterocyclische derivate,die als orexin rezeptor antagonisten geeignet sind
EA200200646A1 (ru) Соединения мочевины, обладающие активностью антагонистов мускариновых рецепторов
BG101806A (bg) Индолови производни като антагонисти на 5-нт рецептори
ATE480252T1 (de) Peptidantagonist von zonulin und dessen verwendung
ATE377597T1 (de) Anilinochinazoline als protein-tyrosin- kinasehemmer
IT1306704B1 (it) Anticorpi monoclonali e suoi derivati sintetici o biotecnologici ingrado di agire come molecole antagoniste per il ngf.
BR0110079A (pt) Combinação de compostos orgânicos
Berg et al. Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons
DE60205234D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
DK0760811T3 (da) Imidazolderivater som histaminreceptor H3-modulatorer
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
DE69636437D1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
Boger et al. Cytokine receptor dimerization and activation: prospects for small molecule agonists
ATE211737T1 (de) Tricyclisch substituierte 2,4-dithi(oxo)- pyrimidin-5-yl-verbindungen als p2- purinoceptor- antagonisten
Hill et al. Kinetic analysis of fluorescent ligand binding to cell surface receptors: Insights into conformational changes and allosterism in living cells
WO2005116052A3 (en) ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
PT1042320E (pt) Novos compostos que sao antagonistas de receptores duplos de ourinoceptores p2 e de proteina g 7-transmembranar
ATE227276T1 (de) Neue pyrimidinderivate
EP0862627A4 (de) Rezeptor des y-y5 neuropeptids
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties